[1] BARBEIRO S, MARTINSC A,GONÇALVES C. Duodenal and colonic metastases of ovarian neoplasm[J]. GE Port J Gastroenterol, 2015, 22(4): 175-177.
[2] TORRES M, MATTA E, CHINEA B, et al. Malignant tumors of the small intestine[J]. J Clin Gastroenterol, 2003, 37(5): 372-380.
[3] MANDAL A, LITTLER Y, LIBERTINY G. Asymptomatic renal cell carcinoma with metastasis to the skin and duodenum: a case report and review of the literature[J]. BMJ Case Rep, 2012, 2012: bcr0220125764.
[4] NAEF M, BÜHLMANN M, BAER H U. Small bowel tumors: diagnosis, therapy and prognostic factors[J]. Langenbecks Arch Surg, 1999, 384(2): 176-180.
[5] HONG Y W, KUO I M, LIU Y Y, et al. The role of surgical management in primary small bowel lymphoma: A single-center experience[J]. Eur J Surg Oncol, 2017, 43(10): 1886-1893.
[6] DAHDALEH F S, LORENZEN A, RAJPUT M, et al. The value of preoperative imaging in small bowel neuroendocrine tumors[J]. Ann Surg Oncol, 2013, 20(6): 1912-1917.
[7] DESOUKI M M, LIOYD J, XU H D,et al. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary[J]. Hum Pathol, 2013, 44(11): 2536-2541. |
